Orrick Advises Twist Bioscience on $107.4 Million Follow-On Offering


Orrick has advised San Francisco-based synthetic biology company Twist Bioscience (NASDAQ: TWST) on its $107.4 million follow-on offering of 3,484,848 shares of common stock at $33.00 per share, which includes full exercise of the underwriters’ option to purchase additional shares.

The offering closed on June 8, 2020. J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C. acted as joint book-running managers and Robert W. Baird & Co. Incorporated acted as lead manager for the offering.

The Orrick team advising Twist on its follow-on offering includes Bill Hughes, John Bautista, Lynne Hirata, Mark Nguyen and Nanette Agustines.